Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.10. rezultāts no 100.
32. lappuse
... tablets . ( ii ) Extraction . Transfer 10.0 milli- liters of each of the six filtrates , 10.0 milliliters of each of the five standard solutions , and 10.0 milliliters of dis- solution medium , to provide a blank , in separate 60 ...
... tablets . ( ii ) Extraction . Transfer 10.0 milli- liters of each of the six filtrates , 10.0 milliliters of each of the five standard solutions , and 10.0 milliliters of dis- solution medium , to provide a blank , in separate 60 ...
41. lappuse
... tablets or capsules ) , and containing 30 milligrams or more of iron per dosage unit , are exempt from the provisions of paragraph ( a ) of this section until January 15 , 1998 , if the sole source of iron in the drug product is ...
... tablets or capsules ) , and containing 30 milligrams or more of iron per dosage unit , are exempt from the provisions of paragraph ( a ) of this section until January 15 , 1998 , if the sole source of iron in the drug product is ...
127. lappuse
... of dosage units of each strength or po- tency distributed ( e.g. , 100,000 / 5 milli- gram tablets , 50,000 / 10 milliliter vials ) , and the quantities distributed for do- mestic use and the 127 Food and Drug Administration , HHS §314.81.
... of dosage units of each strength or po- tency distributed ( e.g. , 100,000 / 5 milli- gram tablets , 50,000 / 10 milliliter vials ) , and the quantities distributed for do- mestic use and the 127 Food and Drug Administration , HHS §314.81.
271. lappuse
... tablets . A fluoride treatment rinse prepared by adding an effervescent tablet ( a con- centrated solid dosage form ) to water before using to result in the appro- priate fluoride concentration specified in the monograph . ( m ) ...
... tablets . A fluoride treatment rinse prepared by adding an effervescent tablet ( a con- centrated solid dosage form ) to water before using to result in the appro- priate fluoride concentration specified in the monograph . ( m ) ...
273. lappuse
... tablets used to prepare treatment rinses . " Do not use as a rinse until all the " ( select one of the following : " powder " or " tablet " ) " has dissolved . ' ( 4 ) For anticaries preventive treatment gel products . Adults and ...
... tablets used to prepare treatment rinses . " Do not use as a rinse until all the " ( select one of the following : " powder " or " tablet " ) " has dissolved . ' ( 4 ) For anticaries preventive treatment gel products . Adults and ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning